In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Diabetic ketoacidosis
Recommendations for action in practice
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Severe acute pancreatitis
COX-2 inhibition alleviates inflammation and improves outcomes
- Ulcerative colitis
Rgs14 protein can worsen the severity
- Mastocytosis
Innovative pathogenesis-based therapeutic approaches in the pipeline
- Participation of the patient
Adherence in psychiatry
- Psychooncology
Communication as the key to therapy adherence
- Acute myeloid leukemia